Radiopharm Theranostics Ltd (RADX) Form 10-Q Quarterly Reports
Radiopharm Theranostics Ltd (RADX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RADX
CIK: 1949257
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: C3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton Audit Pty Ltd
Auditor SinceSince 6/30/2022 12:00:00 AM
Lead Engagement PartnerMichael Cunningham
Audit LocationMelbourne, Australia
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-14 | — | SCHEDULE 13G Filing | 0001214659-26-012928 | View SEC Doc Filr Page |
| 6-K | 2026-10-05 | 2026-10-05 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-106652 | View SEC Doc Filr Page |
| 6-K | 2026-10-01 | 2026-10-01 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-105456 | View SEC Doc Filr Page |
| 20-F | 2026-09-30 | 2026-06-30 | ANNUAL REPORT | 0001213900-26-105181 | View SEC Doc Filr Page |
| 6-K | 2026-09-30 | 2026-09-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-104850 | View SEC Doc Filr Page |
| EFFECT | 2026-09-23 | — | EFFECT Filing | 9999999995-26-003045 | View SEC Doc Filr Page |
| 424B3 | 2026-09-23 | — | PROSPECTUS | 0001213900-26-102669 | View SEC Doc Filr Page |
| 6-K | 2026-09-22 | 2026-09-22 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-101968 | View SEC Doc Filr Page |
| 6-K | 2026-09-14 | 2026-09-14 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-099435 | View SEC Doc Filr Page |
| F-3 | 2026-09-14 | — | REGISTRATION STATEMENT | 0001213900-26-099432 | View SEC Doc Filr Page |
| 6-K | 2026-09-11 | 2026-09-11 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-098976 | View SEC Doc Filr Page |
| 6-K | 2026-09-09 | 2026-09-09 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-098219 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-04 | — | SCHEDULE 13G Filing | 0001193125-26-383762 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-04 | — | SCHEDULE 13D Filing | 0001193125-26-383754 | View SEC Doc Filr Page |
| 6-K | 2026-08-28 | 2026-08-28 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-094655 | View SEC Doc Filr Page |
| 6-K | 2026-08-27 | 2026-08-27 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-094127 | View SEC Doc Filr Page |
| 6-K | 2026-08-26 | 2026-08-26 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-093730 | View SEC Doc Filr Page |
| 6-K | 2026-08-20 | 2026-08-20 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-091896 | View SEC Doc Filr Page |
| 6-K | 2026-08-17 | 2026-08-17 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-090491 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-08-13 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-088705 | View SEC Doc Filr Page |
| 6-K | 2026-08-03 | 2026-08-03 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-084255 | View SEC Doc Filr Page |
| 6-K | 2026-07-31 | 2026-07-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-083624 | View SEC Doc Filr Page |
| 6-K | 2026-07-28 | 2026-07-28 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-082101 | View SEC Doc Filr Page |
| 6-K | 2026-07-28 | 2026-07-28 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-081991 | View SEC Doc Filr Page |
| 6-K | 2026-07-27 | 2026-07-27 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-081559 | View SEC Doc Filr Page |